Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Early Olezarsen Therapy: A leap in triglyceride management
Copy link
Facebook
Email
Notes
More

Early Olezarsen Therapy: A leap in triglyceride management

New study findings unveil Olezarsen’s potential to halve triglyceride levels with minimal side effects.

Naveen Sankar S's avatar
Naveen Sankar S
Apr 29, 2024
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Early Olezarsen Therapy: A leap in triglyceride management
Copy link
Facebook
Email
Notes
More
Share
A scientific themed illustration representing a breakthrough in medical therapy. The image should depict a serene and hopeful setting, showing a stylized human figure, possibly a patient, holding a glowing orb symbolizing new treatment options. The background should feature soft, soothing colors, with abstract elements symbolizing health and vitality, such as subtle outlines of heartbeats and lipid molecules. The scene should convey a sense of progress and hope, suitable for a medical breakthrough theme.

Topline:

The recent phase 2b trial of Olezarsen, an antisense therapy, demonstrates a significant reduction in triglycerides by approximately 50%, presenting a promising new treatment avenue for patients with elevated cardiovascular risks and healthcare providers looking for effective management options.

Study Details:

The Olezarsen study, termed BRIDGE-TI…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More